UBS AM’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.2M Buy
1,255,803
+183,329
+17% +$1.05M ﹤0.01% 1521
2025
Q1
$8.75M Buy
1,072,474
+113,803
+12% +$929K ﹤0.01% 1287
2024
Q4
$9.03M Buy
958,671
+471,902
+97% +$4.45M ﹤0.01% 1298
2024
Q3
$5.2M Sell
486,769
-47,310
-9% -$505K ﹤0.01% 1548
2024
Q2
$5.3M Buy
534,079
+282,846
+113% +$2.81M ﹤0.01% 1450
2024
Q1
$2.96M Sell
251,233
-6,567
-3% -$77.4K ﹤0.01% 1489
2023
Q4
$3.66M Buy
257,800
+11,761
+5% +$167K ﹤0.01% 1400
2023
Q3
$2.99M Sell
246,039
-25,363
-9% -$308K ﹤0.01% 1434
2023
Q2
$3.01M Hold
271,402
﹤0.01% 1453
2023
Q1
$3.01M Buy
271,402
+21,731
+9% +$241K ﹤0.01% 1453
2022
Q4
$3.05M Buy
249,671
+28,777
+13% +$351K ﹤0.01% 1352
2022
Q3
$2.31M Sell
220,894
-50,585
-19% -$528K ﹤0.01% 1528
2022
Q2
$2.92M Buy
271,479
+2,453
+0.9% +$26.3K ﹤0.01% 1449
2022
Q1
$2.55M Sell
269,026
-10,461
-4% -$99.1K ﹤0.01% 1672
2021
Q4
$3.23M Sell
279,487
-6,154
-2% -$71.1K ﹤0.01% 1626
2021
Q3
$2.73M Sell
285,641
-39,196
-12% -$374K ﹤0.01% 1692
2021
Q2
$3.13M Buy
324,837
+10,288
+3% +$99.2K ﹤0.01% 1637
2021
Q1
$3.11M Buy
314,549
+26,457
+9% +$261K ﹤0.01% 1562
2020
Q4
$6.65M Sell
288,092
-1,217,486
-81% -$28.1M ﹤0.01% 1185
2020
Q3
$21.3M Buy
1,505,578
+1,215,044
+418% +$17.2M 0.01% 746
2020
Q2
$4.38M Sell
290,534
-4,061
-1% -$61.2K ﹤0.01% 1169
2020
Q1
$2.72M Buy
294,595
+18,286
+7% +$169K ﹤0.01% 1290
2019
Q4
$2.69M Buy
276,309
+28,188
+11% +$275K ﹤0.01% 1467
2019
Q3
$1.99M Buy
248,121
+40,135
+19% +$322K ﹤0.01% 1614
2019
Q2
$2.6M Buy
207,986
+50,218
+32% +$627K ﹤0.01% 1460
2019
Q1
$2.15M Buy
157,768
+20,446
+15% +$278K ﹤0.01% 1483
2018
Q4
$1.32M Buy
137,322
+19,811
+17% +$190K ﹤0.01% 1621
2018
Q3
$1.42M Sell
117,511
-1,334
-1% -$16.1K ﹤0.01% 1651
2018
Q2
$1.86M Sell
118,845
-5,117
-4% -$79.9K ﹤0.01% 1537
2018
Q1
$1.86M Buy
123,962
+19,017
+18% +$286K ﹤0.01% 1495
2017
Q4
$1.51M Buy
104,945
+40,793
+64% +$587K ﹤0.01% 1560
2017
Q3
$967K Buy
64,152
+13,396
+26% +$202K ﹤0.01% 1728
2017
Q2
$511K Buy
50,756
+82
+0.2% +$826 ﹤0.01% 1877
2017
Q1
$361K Buy
50,674
+21,174
+72% +$151K ﹤0.01% 1954
2016
Q4
$147K Sell
29,500
-15,500
-34% -$77.2K ﹤0.01% 2198
2016
Q3
$333K Hold
45,000
﹤0.01% 2207
2016
Q2
$246K Sell
45,000
-550,060
-92% -$3.01M ﹤0.01% 2323
2016
Q1
$5.03M Sell
595,060
-361,125
-38% -$3.05M 0.01% 1021
2015
Q4
$9.28M Buy
956,185
+5,700
+0.6% +$55.3K 0.01% 885
2015
Q3
$13.3M Sell
950,485
-81,415
-8% -$1.14M 0.01% 797
2015
Q2
$14.6M Buy
1,031,900
+21,900
+2% +$310K 0.01% 795
2015
Q1
$11M Buy
1,010,000
+17,600
+2% +$191K 0.01% 857
2014
Q4
$8.26M Buy
992,400
+6,400
+0.6% +$53.2K 0.01% 925
2014
Q3
$5.87M Sell
986,000
-386,700
-28% -$2.3M 0.01% 997
2014
Q2
$4.59M Sell
1,372,700
-1,082,700
-44% -$3.62M ﹤0.01% 1052
2014
Q1
$5.08M Hold
2,455,400
0.01% 1035
2013
Q4
$5.77M Hold
2,455,400
0.01% 977
2013
Q3
$5.7M Buy
2,455,400
+1,211,200
+97% +$2.81M 0.01% 946
2013
Q2
$2.9M Buy
+1,244,200
New +$2.9M ﹤0.01% 1094